CA2107229A1 - Medicaments a saveur masquee et leur preparation - Google Patents

Medicaments a saveur masquee et leur preparation

Info

Publication number
CA2107229A1
CA2107229A1 CA 2107229 CA2107229A CA2107229A1 CA 2107229 A1 CA2107229 A1 CA 2107229A1 CA 2107229 CA2107229 CA 2107229 CA 2107229 A CA2107229 A CA 2107229A CA 2107229 A1 CA2107229 A1 CA 2107229A1
Authority
CA
Canada
Prior art keywords
taste
masked
medicaments
preparation
cellulose ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2107229
Other languages
English (en)
Other versions
CA2107229C (fr
Inventor
Thomas A. Wheatley
David Frank Erkoboni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2107229A1 publication Critical patent/CA2107229A1/fr
Application granted granted Critical
Publication of CA2107229C publication Critical patent/CA2107229C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Médicaments solide au goût masqué, comme un comprimé d'aspirine ou un autre médicament semblable, dont le goût est masqué au moyen d'une mince pellicule d'ester de cellulose formée par le revêtement séché d'une dispersion aqueuse d'ester de cellulose plastifiée. La pellicule ne représente pas plus d'environ 1 partie en pourcentage du médicament pelliculé.
CA002107229A 1991-04-30 1992-04-03 Medicaments a saveur masquee et leur preparation Expired - Fee Related CA2107229C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69373291A 1991-04-30 1991-04-30
US693,732 1991-04-30

Publications (2)

Publication Number Publication Date
CA2107229A1 true CA2107229A1 (fr) 1992-10-31
CA2107229C CA2107229C (fr) 1997-07-22

Family

ID=24785870

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002107229A Expired - Fee Related CA2107229C (fr) 1991-04-30 1992-04-03 Medicaments a saveur masquee et leur preparation

Country Status (6)

Country Link
EP (1) EP0583399A4 (fr)
JP (1) JP2538491B2 (fr)
AU (1) AU651721B2 (fr)
CA (1) CA2107229C (fr)
NO (1) NO933920L (fr)
WO (1) WO1992019209A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
JP2007031281A (ja) * 2003-06-25 2007-02-08 Kowa Co イブプロフェン含有フィルムコーティング錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals

Also Published As

Publication number Publication date
AU2167392A (en) 1992-12-21
WO1992019209A2 (fr) 1992-11-12
AU651721B2 (en) 1994-07-28
NO933920D0 (no) 1993-10-29
WO1992019209A3 (fr) 1993-01-07
CA2107229C (fr) 1997-07-22
JP2538491B2 (ja) 1996-09-25
EP0583399A4 (en) 1997-04-23
NO933920L (no) 1993-10-29
JPH06501027A (ja) 1994-01-27
EP0583399A1 (fr) 1994-02-23

Similar Documents

Publication Publication Date Title
CA2068402A1 (fr) Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables
CA2145513A1 (fr) Comprime pouvant liberer a differentes vitesses un ou plusieurs medicaments
AU1992595A (en) Hydrophobic drug delivery systems
CA2042289A1 (fr) Enrobage qui masque le gout des produits pharmaceutiques et qui permet une liberation lente
CA2074309A1 (fr) Formulations stabilisees a liberation controlee, presentant une couche de polymere acrylique
CA2038245A1 (fr) Micropellets utiles en pharmacologie
DK205889D0 (da) Vandbaseret farmaceutisk overtraeksmateriale til doseringsformer
CA2304110A1 (fr) Comprime de theophylline a liberation prolongee
CA2103306A1 (fr) Compositions extrudables pour la delivrance topique ou transdermique de medicaments
RU92004344A (ru) Устойчивые лекарственные формы с регулируемым выделением, имеющие акриловые полимерные покрытия, и способ их получения
CA2046739A1 (fr) Forme posologique solide enrobee a liberation dans le colon
FR2704146B1 (fr) Microcapsules d'acide acétylsalicylique à libération contrôlée.
CA2021574A1 (fr) Preparation pharmaceutique a fragmentation rapide, au gout desagreable masque, pour administration par voie buccale
CA2061824A1 (fr) Substrat stabilise a liberation-retard, comportant un revetement derive d'une dispersion aqueuse de polymere hydrophobe
CA2148465A1 (fr) Preparation pharmaceutique orale, pouvant etre liberee dans la voie digestive inferieure
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
AU635021B2 (en) Extended release pharmaceutical formulations
AU6764390A (en) Pharmaceutical granules and drug dosage units made therefrom
AU647518B2 (en) Coating base for pharmaceutical film and production thereof
IT9019571A0 (it) Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CA2041044A1 (fr) Formule orale de series polypeptidiques dissociatives pour le gros intestin
AU590370B2 (en) Improvements in or relating to pharmaceutical products
MY103455A (en) Chewable medicament tablet containing means for taste masking
AU8714091A (en) Combination of hyaluronic acid with medicinal ingredient and production thereof
CA2052679A1 (fr) Rotogranulations et enrobages masquant les saveurs dans la preparation de comprimes pharmaceutiques a croquer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20000403